Profile
Eric M.
Krauland is currently the President & Chief Scientific Officer at Adimab LLC.
He holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from The Johns Hopkins University.
Eric M. Krauland active positions
| Companies | Position | Start |
|---|---|---|
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | President | 2022-05-08 |
Training of Eric M. Krauland
| The Johns Hopkins University | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Health Technology |
- Stock Market
- Insiders
- Eric M. Krauland
